Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation

Wang, Y., Gogol-Doring, A., Hu, H., Frohler, S., Ma, Y., Jens, M., et al. (2013). Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation. EMBO Molecular Medicine, 5(9), 1431-1442. doi:10.1002/emmm.201302663.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
Wang.pdf (Verlagsversion), 2MB
Name:
Wang.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
© 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Wang, Y., Autor
Gogol-Doring, A., Autor
Hu, H.1, Autor           
Frohler, S., Autor
Ma, Y., Autor
Jens, M., Autor
Maaskola, J., Autor
Murakawa, Y., Autor
Quedenau, C., Autor
Landthaler, M., Autor
Kalscheuer, V.2, Autor           
Wieczorek, D., Autor
Wang, Y., Autor
Hu, Y., Autor
Chen, W.1, Autor           
Affiliations:
1Dept. of Human Molecular Genetics (Head: Hans-Hilger Ropers), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433549              
2Chromosome Rearrangements and Disease (Vera Kalscheuer), Dept. of Human Molecular Genetics (Head: Hans-Hilger Ropers), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479642              

Inhalt

einblenden:
ausblenden:
Schlagwörter: RBM10, alternative splicing, mechanistic model
 Zusammenfassung: RBM10 encodes an RNA binding protein. Mutations in RBM10 are known to cause multiple congenital anomaly syndrome in male humans, the TARP syndrome. However, the molecular function of RBM10 is unknown. Here we used PAR-CLIP to identify thousands of binding sites of RBM10 and observed significant RBM10-RNA interactions in the vicinity of splice sites. Computational analyses of binding sites as well as loss-of-function and gain-of-function experiments provided evidence for the function of RBM10 in regulating exon skipping and suggested an underlying mechanistic model, which could be subsequently validated by minigene experiments. Furthermore, we demonstrated the splicing defects in a patient carrying an RBM10 mutation, which could be explained by disrupted function of RBM10 in splicing regulation. Overall, our study established RBM10 as an important regulator of alternative splicing, presented a mechanistic model for RBM10-mediated splicing regulation and provided a molecular link to understanding a human congenital disorder.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2013-08-222013-09
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1002/emmm.201302663
ISSN: 1757-4684 (Electronic)1757-4676 (Print)
URI: http://www.ncbi.nlm.nih.gov/pubmed/24000153
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: EMBO Molecular Medicine
  Kurztitel : EMBO Mol Med
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: John Wiley and Sons, Ltd
Seiten: - Band / Heft: 5 (9) Artikelnummer: - Start- / Endseite: 1431 - 1442 Identifikator: -